VSM Wealth Advisory’s AbbVie ABBV Stock Holding History

VSM Wealth Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Hold	866	–	–	0.06%	106
2026 Q1	$188K	Sell	866 -74	-8%	-$16.4K	0.06%	111
2025 Q4	$215K	Sell	940 -75	-7%	-$17.1K	0.06%	100
2025 Q3	$235K	Buy	1,015 +1	+0.1%	+$204	0.07%	80
2025 Q2	$188K	Buy	1,014 +48	+5%	+$8.92K	0.06%	97
2025 Q1	$202K	Hold	966	–	–	0.07%	91
2024 Q4	$172K	Buy	+966	New	+$178K	0.06%	95

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

VSM Wealth Advisory's ABBV Position: Q2 2026 in Review

VSM Wealth Advisory held its AbbVie (ABBV) position steady in Q2 2026 at 866 shares worth $218K. The position accounts for 0.06% of the portfolio, ranked #106.

VSM Wealth Advisory first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $235K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

VSM Wealth Advisory held 866 shares of AbbVie worth $218K as of Q2 2026.
VSM Wealth Advisory left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.06% of VSM Wealth Advisory's portfolio in Q2 2026, its #106 holding.
VSM Wealth Advisory first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
VSM Wealth Advisory's AbbVie position peaked at $235K in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.